Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa.

[1]  S. Nsanzimana,et al.  THU-411-Effectiveness of direct: Acting antivirals for the treatment of viral hepatitis C in Rwanda , 2019, Journal of Hepatology.

[2]  R. Peeling,et al.  Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. , 2019, The lancet. Gastroenterology & hepatology.

[3]  J. Mukherjee,et al.  Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial. , 2019, The lancet. Gastroenterology & hepatology.

[4]  M. Alboraie,et al.  Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations , 2018, World journal of gastroenterology.

[5]  J. Ward,et al.  Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework , 2018, Journal of virus eradication.

[6]  S. Nsanzimana,et al.  Is hepatitis C elimination possible in sub-Saharan Africa? The case of Rwanda. , 2018, The lancet. Gastroenterology & hepatology.

[7]  A. Gamkrelidze,et al.  Progress toward hepatitis C virus elimination through provision of care and treatment services, Georgia, 2015–2017 , 2018 .

[8]  T. Qadir,et al.  Tackling hepatitis C—Pakistan's road to success , 2018, The Lancet.

[9]  S. Olafsson,et al.  Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020. , 2017, Journal of hepatology.

[10]  S. Nsanzimana,et al.  Controlling hepatitis C in Rwanda: a framework for a national response , 2017, Bulletin of the World Health Organization.

[11]  Geoffrey Dusheiko,et al.  Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. , 2017, The lancet. Gastroenterology & hepatology.

[12]  J. Lazarus,et al.  Micro-elimination - A path to global elimination of hepatitis C. , 2017, Journal of hepatology.

[13]  John Stover,et al.  Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries , 2017, The Lancet. Global health.

[14]  N. Ford,et al.  Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda , 2017, BMC Infectious Diseases.

[15]  D. Mcintyre,et al.  Fiscal space for domestic funding of health and other social services , 2017, Health Economics, Policy and Law.

[16]  J. Mukherjee,et al.  “Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda , 2017, PloS one.

[17]  Gamal Esmat,et al.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.

[18]  A. Bungert,et al.  Hepatitis prevention, control, and elimination program in Mongolia: national hepatitis elimination program in a country with the highest burden of viral hepatitis in the world , 2017 .

[19]  P. Böelle,et al.  Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta‐analysis , 2016, Journal of viral hepatitis.